PLoS ONE · 2015 · 14 citations · 23 references
MedicineGeneticsMolecular BiologyDiagnostic MicrobiologyMicrobial GeneticsMolecular DiagnosticsInfectious Disease Molecular TestingMutation AnalysisMycobacterial DiagnosticsNucleic Acid Amplification TestingTuberculosis DiagnosisTuberculosis Diagnostic TestingGenetic Mutation DetectionInternal Amplification ControlsMutationNucleic Acid AmplificationRapid Detection AssaysRapid Molecular DiagnosticsReal-time Polymerase Chain Reaction (Pcr)Tuberculosis Molecular Testing
Drug-resistant Mycobacterium tuberculosis can be rapidly diagnosed through nucleic acid amplification techniques by analyzing the variations in the associated gene sequences. In the present study, a locked nucleic acid (LNA) probe-based real-time PCR assay was developed to identify the mutations in the rpoB gene associated with rifampin (RFP) resistance in M. tuberculosis. Six LNA probes with the discrimination capability of one-base mismatch were designed to monitor the 23 most frequent rpoB mutations. The target mutations were identified using the probes in a "probe dropout" manner (quantification cycle = 0); thus, the proposed technique exhibited superiority in mutation detection. The LNA probe-based real-time PCR assay was developed in a two-tube format with three LNA probes and one internal amplification control probe in each tube. The assay showed excellent specificity to M. tuberculosis with or without RFP resistance by evaluating 12 strains of common non-tuberculosis mycobacteria. The limit of detection of M. tuberculosis was 10 genomic equivalents (GE)/reaction by further introducing a nested PCR method. In a blind validation of 154 clinical mycobacterium isolates, 142/142 (100%) were correctly detected through the assay. Of these isolates, 88/88 (100%) were determined as RFP susceptible and 52/54 (96.3%) were characterized as RFP resistant. Two unrecognized RFP-resistant strains were sequenced and were found to contain mutations outside the range of the 23 mutation targets. In conclusion, this study established a sensitive, accurate, and low-cost LNA probe-based assay suitable for a four-multiplexing real-time PCR instrument. The proposed method can be used to diagnose RFP-resistant tuberculosis in clinical laboratories.
23
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Catharina Boehme, Pamela Nabeta, Doris Hillemann et al. · New England Journal of Medicine · 2010 · 2.3K citations · Full text
Danica Helb, Martin Jones, Elizabeth Story‐Roller et al. · Journal of Clinical Microbiology · 2009 · 920 citations · Full text
Grant Theron, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2013 · 444 citations